entertainment
Previous article:
How to save PrEP access — and even expand it
Next article: ARCH Venture Partners tops STAT's 2023 biotech VC rankings
Next article: ARCH Venture Partners tops STAT's 2023 biotech VC rankings
focus
explore
-
Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech
2025-08-31 01:13 -
Abortion pill case raises question: who can sue the FDA?
2025-08-31 00:55 -
Decaf coffee targeted by food safety group under obscure FDA rule
2025-08-31 00:48 -
Listen: Wegovy in the brain & pivotal Alzheimer's data
2025-08-31 00:29 -
Custom gene therapy hints at new path for rare disease treatments
2025-08-30 23:32 -
FDA's naming rule on biosimilars has undermined competition
2025-08-30 23:15